Brief: Drugmakers Mallinckrodt And Endo Are In Talks To Merge That Could Be Valued At About $7 Billion - Bloomberg News
March 12 (Reuters) - DRUGMAKERS MALLINCKRODT AND ENDO ARE IN TALKS TO MERGE THAT COULD BE VALUED AT ABOUT $7 BILLION - BLOOMBERG NEWS Source text: https://tinyurl.com/2brshd4o Further company coverage: NDOI.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo
See all newsBrief: Mallinckrodt, Endo Announce Planned Leadership Team For Merged Company
Brief: Endo To Report First Quarter 2025 Financial Results On May 7, 2025
Deals of the day-Mergers and acquisitions
Corrected: Deals of the day-Mergers and acquisitions
To Pay Endo $80.2 Million Termination Fee If Deal Is Terminated Under Certain Conditions